secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001493152-23-035239
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem raises $1.5M via $2.88M convertible notes with warrants at $0.13 strike
------------------------------------------------------------------------------

- Issued $2,884,615 principal of 8% senior subordinate convertible notes due Sept 2026, convertible at $0.13/share.
- Sold at 65% of face value; net proceeds approximately $1.5 million after offering costs.
- Warrants: Series A (22.2M shares at $0.13) and prepaid Series B (4.8M shares at $0.001 after $0.129 prepayment).
- Beneficial ownership blocker set at 4.99%; company must file registration statement within 90 days.
- Covenants restrict additional debt, liens, dividends, and require auditor registered with PCAOB.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223035239/0001493152-23-035239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223035239/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-035239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer